Cannabis Law Report

MARCH 7, 2019

Switzerland’s government will allow 5,000 citizens to use cannabis legally, as part of a country-wide clinical trial. Lawmakers backed scientific studies into the impact of cannabis on public health and safety, ahead of potential regulation, however any rule change is unlikely to occur in the next decade unless fast-tracked.

Clinical Trials 56

Clinical Trials Research and Development Decriminalization Environment 56

Cannabis Law Report

JANUARY 14, 2020

The MORE Act would decriminalize marijuana and THC at the federal level by removing it from Schedule I of the Controlled Substances Act, which currently classifies it as an addictive drug that has no accepted medical use, akin to heroin. 171, Legitimate Use of Medicinal Marijuana Act. 1151, Veterans Medical Marijuana Safe Harbor Act.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

Cannabis Law Report

JUNE 10, 2021

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 45

Policy Safety Marijuana Data 45

MMJ Recs

JULY 3, 2024

Federally, the 2018 Farm Bill decriminalized hemp-derived CBD with less than 0.3% For qualifying patients, staying informed about local regulations through state health department resources and reputable CBD retailers is essential to ensure compliance and safety. THC, marking a significant shift toward legality.

CBD 52

CBD Research and Development Clinical Trials THC 52

The Cannigma

AUGUST 26, 2021

Medical: Legal Recreational: Illegal (though at least one territory has adopted decriminalization). This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness. percent) remains far higher than the world average (3.9 percent), according to the United Nations World Drug Report for 2020.In

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

SEPTEMBER 23, 2022

Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of psychedelics. The continued criminalization of all drugs and the people who use them increases harms to public health and safety.

Decriminalization 52

Decriminalization Advocacy Research and Development Clinical Trials 52

Cannabis Law Report

MAY 29, 2022

7] And cities around the country are beginning to decriminalize some psychedelics, with advocates for decriminalization citing the potential medical benefits. In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. And in my belief, it should be cannabis, because of the safety profile, number one.

Legalization 132

Legalization Patients Education Dispensary 132

Cannabis Law Report

JULY 21, 2022

The comprehensive legislation would end federal cannabis prohibition by removing cannabis from the Controlled Substances Act; empower states to create their own cannabis laws; ensure federal regulation protects public health and safety; and prioritize restorative and economic justice .

Safety 52

Safety Legislation Clinical Trials Banking 52

Canna Law Blog

MARCH 4, 2020

Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).

Legalization 56

Legalization Therapy Chronic Pain DEA 56

Cannabis Law Report

AUGUST 30, 2019

Americans for Safe Access released its 2018-2019 State-of-the-State report examining state laws and regulations surrounding Patient Rights and Civil Protection from Discrimination, Access to Medicine, Ease of Navigation, Functionality of the Programs, and Consumer Safety and Provider Requirements. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. In 2018, he helped guide the Decriminalize Denver campaign in the process of drafting the initiative text. Rick Doblin, Ph.D,

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Many of these are meant to address public safety risks, especially for young people.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. Jimmy Higdon’s Cannabis Decriminalization (SB 82), and Sen. Kentucky’s Senate leader has taken a contradictory stance. 8 – state Rep.

Data 190

Data Clinical Trials Chronic Pain Medicine 190